Size | Price | Stock | Qty |
---|---|---|---|
25mg |
|
||
50mg |
|
||
100mg |
|
||
250mg |
|
||
500mg |
|
||
1g |
|
||
2g |
|
||
Other Sizes |
|
Purity: ≥98%
CRT0044876 (CRT-0044876; NSC 69877, 7-NO2-ICA; NSC-69877; CRT 0044876; NSC69877), an indole analog, is a potent and selective APE1 inhibitor with potential antitumor activity. With an IC50 of about 3 μM, it inhibits APE1.
Targets |
APE1 ( IC50 ~ 3 μM )
|
||
---|---|---|---|
ln Vitro |
|
||
ln Vivo |
|
||
Enzyme Assay |
The components of the BER reaction buffer are 0.5 mM DTT, 0.1 mM EDTA, 5 mM MgCl2, and 40 mM HEPES–KOH (pH 7.8). 0.75 ng of reduced AP site double-stranded oligonucleotide, purified protein (3.3 nM final concentration of APE1), and BER buffer mix were added to a 10 μl AP site cleavage reaction. The mixture is incubated for one hour at 37°C. After adding 1 μl of stop buffer (consisting of 50% glycerol, 10 mM Tris–HCl, 1 mM EDTA, 0.1% bromophenol blue, and 0.1% Xylene cyanol), the sample mixture is denatured for two minutes at 90–100°C. The sample is then electrophoresed at a constant current of 30 mA for 30 minutes on a 15% TBE CriterionTM Pre-Cast Gel. The radiolabeled substrate and reaction products are then visualized using a phosphorImager. From 0.1 to 100 μM drug concentrations, the inhibitory activity of putative APE1-targeting compounds is scrutinized. IC50 values are computed by finding the concentration of the inhibitor that decreased APE1 activity to 50% of the control values. The quantification of the resolved radiolabeled bands is done using ImageQuant software investigation.
|
||
Cell Assay |
The culture medium used for HT1080 fibrosarcoma cells is 2% RPMI supplemented with 0.06 g/l penicillin, 0.1 g/l streptomycin (pH 7.0), 10% fetal bovine serum, and 4 mM glutamine. For clonogenic survival analysis, only cells with a plating efficiency of ≥60% are employed. 500 cells are seeded into 10-cm tissue culture dishes, and the cultures are kept in an environment of 95% air and 5% CO2 at 37°C in a humidified incubator. In order to assess the toxicity profile of potential APE1 inhibitors, the medium is supplemented with inhibitor at different concentrations (100–500 μM), and cultures are incubated for 7–10 days until cell colonies form. After fixing (75 percent methanol and 25 percent acetic acid) for 30 minutes, the colonies are stained for four hours at room temperature using crystal violet (1 mg/ml in distilled water). A colony counter is used to count colonies that are visible.
|
||
Animal Protocol |
|
||
References |
Molecular Formula |
C9H6N2O4
|
|
---|---|---|
Molecular Weight |
206.15
|
|
Exact Mass |
206.16
|
|
Elemental Analysis |
C, 52.44; H, 2.93; N, 13.59; O, 31.04
|
|
CAS # |
6960-45-8
|
|
Related CAS # |
|
|
Appearance |
Solid powder
|
|
SMILES |
C1=CC2=C(C(=C1)[N+](=O)[O-])NC(=C2)C(=O)O
|
|
InChi Key |
BIUCOFQROHIAEO-UHFFFAOYSA-N
|
|
InChi Code |
InChI=1S/C9H6N2O4/c12-9(13)6-4-5-2-1-3-7(11(14)15)8(5)10-6/h1-4,10H,(H,12,13)
|
|
Chemical Name |
7-nitro-1H-indole-2-carboxylic acid
|
|
Synonyms |
|
|
HS Tariff Code |
2934.99.9001
|
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO : 41~50 mg/mL (198.9~242.5 mM)
Ethanol : ~1 mg/mL (~4.9 mM) |
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: 2.5 mg/mL (12.13 mM) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 4.8508 mL | 24.2542 mL | 48.5084 mL | |
5 mM | 0.9702 mL | 4.8508 mL | 9.7017 mL | |
10 mM | 0.4851 mL | 2.4254 mL | 4.8508 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.